A clear and present danger: Tick-borne diseases in Europe

Expert Review of Anti-Infective Therapy

Volumn 8, Issue 1, 2010, Pages 33-50

  Heyman, Paul ^a   Cochez, Christel ^a   Hofhuis, Agnetha ^b   Van Der Giessen, Joke ^b   Sprong, Hein ^b   Porter, Sarah Rebecca ^c   Losson, Bertrand ^c   Saegerman, Claude ^c   Donoso Mantke, Oliver ^d   Niedrig, Matthias ^d   Papa, Anna ^e  

^a QUEEN ASTRID MILITARY HOSPITAL   (Belgium)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d ROBERT KOCH INSTITUTE   (Germany)

^e ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Anaplasma phagocytophilum; Babesia; Borrelia; Crimean Congo hemorrhagic fever virus; Europe; Rickettsia; tick borne diseases; tick borne encephalitis virus

Indexed keywords

DOXYCYCLINE; LYME DISEASE VACCINE;

ANAPLASMA PHAGOCYTOPHILUM; ANAPLASMOSIS; BABESIA; BABESIOSIS; CLIMATE CHANGE; CLINICAL FEATURE; CRIMEAN CONGO HEMORRHAGIC FEVER; DISEASE COURSE; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EUROPE; GENETIC VARIABILITY; HUMAN; HUMAN GRANULOCYTIC ANAPLASMOSIS; LABORATORY DIAGNOSIS; LYME DISEASE; NAIRO VIRUS; NONHUMAN; PREDATOR PREY INTERACTION; REVIEW; RICKETTSIA; RICKETTSIOSIS; SPECIES DISTRIBUTION; TICK BORNE DISEASE; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VIRUS PATHOGENESIS; VIRUS STRAIN; ANIMAL; ENCEPHALITIS; MICROBIOLOGY; PARASITE VECTOR; PARASITOLOGY; PHYSIOLOGY; RICKETTSIACEAE INFECTION; TICK;

ANAPLASMOSIS; ANIMALS; ARACHNID VECTORS; BABESIOSIS; ENCEPHALITIS; EUROPE; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; LYME DISEASE; RICKETTSIACEAE INFECTIONS; TICK-BORNE DISEASES; TICKS;

EID: 77954481714     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.09.118     Document Type: Review

References (244)

1. Krantz GW. A Manual of Acarology. Corvallis I (Eds.). Oregon Sta. Univ. Book Stores, Salem, MA, USA, 509 (1978).
2. Arthur DR. Ticks in Egypt in 1500 B.C.? Nature 206(988), 1060-1061 (1965).
3. Hoogstraal H. Changing patterns of tickborne diseases in modern society. Annu. Rev. Entomol. 26, 75-99 (1981).
4. Johnson KL, Reinhardt KJ, Sianto L, Araujo A, Gardner SL, Janovy J Jr. A tick from a prehistoric Arizona coprolite. J. Parasitol. 94(1), 296-298 (2008). (Pubitemid 351415463)
5. Mcllwain JT. The 'Bodelye syeknes' of Julian of Norwich. J. Medieval History 10(3), 167-180 (1984).
6. Assadian O, Stanek G. Theobald Smith: the discoverer of ticks as vectors of disease. Wien. Klin. Wochenschr. 114, 478-481 (2002).
7. Buchwald A. Ein fall von diffuser idiopathischer haut atrophie. Arch. Derm. Syph. 15, 553-556 (1883).
8. Herxeimer K, Hartman K. Uber Acrodermatitis Chronica Atrophicans. Acta. Dermatol. 61, 57-76 (1902).
9. Afzelius A. Verhandlungen der dermatologischen gesellschaft zu Stockholm. Arch. Dermatol. Syph. 101-104 (1910).
10. Lipschutz B. Uber eine seltene erythemaform (erythema chronicum migrans). Arch. Dermatol. Syph. 118, 349-356 (1914).
11. Hovius JW, Levi M, Fikrig E. Salivating for knowledge: potential pharmacological agents in tick saliva. PLoS Med. 5(2), e43 (2008).
12. Labuda M, Trimnell AR, Lickova M et al. An antivector vaccine protects against a lethal vector-borne pathogen. PLoS Pathog. 2(4), e27 (2006).
13. + T cell activation. Immunity 16(6), 849-859 (2002). (Pubitemid 34786483)
14. Leboulle G, Crippa M, Decrem Y et al. Characterization of a novel salivary immunosuppressive protein from Ixodes ricinus ticks. J. Biol. Chem. 277(12), 10083-10089 (2002). (Pubitemid 34968118)
15. Burke G, Wikel SK, Spielman A, Telford SR, McKay K, Krause PJ. Hypersensitivity to ticks and Lyme disease risk. Emerg. Infect. Dis. 11(1), 36-41 (2005). (Pubitemid 40093350)
16. de la Fuente J, Kocan KM. Strategies for development of vaccines for control of ixodid tick species. Parasite Immunol. 28(7), 275-283 (2006). (Pubitemid 43967392)
17. Anderson JF, Magnarelli LA. Biology of ticks. Infect. Dis. Clin. North Am. 22(2), 195-215, v (2008). (Pubitemid 351608539)
18. Nava S, Guglielmone AA, Mangold AJ. An overview of systematics and evolution of ticks. Front Biosci. 14, 2857-2877 (2009).
19. Hoogstraal H. Ticks and spirochetes. Acta Trop. 36(2), 133-136 (1979). (Pubitemid 10168345)
20. Hillyard PD. Ticks of North-West Europe. In: Field Studies Council (Eds). The Linnean Society of London, London, UK (1996).
21. Randolph SE. Ticks are not insects: consequences of contrasting vector biology for transmission potential. Parasitol. Today 14(5), 186-192 (1998). (Pubitemid 28197740)
22. Hoogstraal H. Pathogens of Acarina (ticks). Bull. World Health Organ. 55(Suppl. 1), 337-340 (1977).
23. Oorebeek M, Sharrad R, Kleindorfer S. What attracts larval Ixodes hirsti (Acari: Ixodidae) to their host? Parasitol. Res. 104(3), 623-628 (2009).
24. Dantas-Torres F, Oliveira-Filho EF, Soares FA, Souza BO, Valenca RB, Sa FB. Ticks infesting amphibians and reptiles in Pernambuco, Northeastern Brazil. Rev. Bras. Parasitol. Vet. 17(4), 218-221 (2008).
25. Hanson BA, Frank PA, Mertins JW, Corn JL. Tick paralysis of a snake caused by Amblyomma rotundatum (Acari: Ixodidae). J. Med. Entomol. 44(1), 155-157 (2007). (Pubitemid 46382004)
26. Dobson A, Cattadori I, Holt RD et al Sacred cows and sympathetic squirrels: the importance of biological diversity to human health. PLoS Med. 3(6), e231 (2006).
27. Randolph SE, Storey K. Impact of microclimate on immature tick-rodent host interactions (Acari: Ixodidae): implications for parasite transmission. J. Med. Entomol. 36(6), 741-748 (1999). (Pubitemid 129559038)
28. Randolph SE, Miklisova D, Lysy J, Rogers DJ, Labuda M. Incidence from coincidence: patterns of tick infestations on rodents facilitate transmission of tick-borne encephalitis virus. Parasitology 118(Pt 2), 177-186 (1999). (Pubitemid 29051867)
29. Rosa R, Pugliese A, Norman R, Hudson PJ. Thresholds for disease persistence in models for tick-borne infections including non-viraemic transmission, extended feeding and tick aggregation. J. Theor. Biol. 224(3), 359-376 (2003). (Pubitemid 37297432)
30. Randolph SE. Ticks and tick-borne disease systems in space and from space. Adv. Parasitol. 47, 217-243 (2000).
31. Randolph SE. The shifting landscape of tick-borne zoonoses: tick-borne encephalitis and Lyme borreliosis in Europe. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356(1411), 1045-1056 (2001). (Pubitemid 32696249)
32. Englund L, Pringle J. New diseases and increased risk of diseases in companion animals and horses due to transport. Acta. Vet. Scand. Suppl. 100, 19-25 (2003).
33. Nijhof AM, Bodaan C, Postigo M et al. Ticks and associated pathogens collected from domestic animals in The Netherlands. Vector Borne Zoonotic Dis. 7(4), 585-595 (2007).
34. Matjila TP, Nijhof AM, Taoufk A et al. Autochthonous canine babesiosis in The Netherlands. Vet. Parasitol. 131(1-2), 23-29 (2005). (Pubitemid 40807532)
35. Mura A, Masala G, Tola S et al. First direct detection of rickettsial pathogens and a new Rickettsia, 'Candidatus Rickettsia barbariae', in ticks from Sardinia, Italy. Clin. Microbiol. Infect. 14(11), 1028-1033 (2008). (Pubitemid 352748843)
36. Barandika JF, Hurtado A, Garcia-Sanmartin J, Juste RA, Anda P, Garcia-Perez AL. Prevalence of tick-borne zoonotic bacteria in questing adult ticks from northern Spain. Vector Borne Zoonotic Dis. 8(6), 829-835 (2008).
37. Chen SM, Dumler JS, Bakken JS, Walker DH. Identifcation of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J. Clin. Microbiol. 32(3), 589-595 (1994). (Pubitemid 24062927)
38. Dumler JS, Choi KS, Garcia-Garcia JC et al. Human granulocytic anaplasmosis and Anaplasma phagocytophilum. Emerg. Infect. Dis. 11(12), 1828-1834 (2005). (Pubitemid 43361465)
39. Dumler JS, Barbet AF, Bekker CP et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unifcation of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila. Int. J. Syst. Evol. Microbiol. 51(Pt 6), 2145-2165 (2001). (Pubitemid 33110908)
40. de la Fuente J, Naranjo V, Ruiz-Fons F et al. Potential vertebrate reservoir hosts and invertebrate vectors of Anaplasma marginale and A. phagocytophilum in central Spain. Vector Borne Zoonotic Dis. 5(4), 390-401 (2005). (Pubitemid 43203202)
41. Gray JS. Biology of Ixodes species ticks in relation to tick-borne zoonoses. Wien. Klin. Wochenschr. 114(13-14), 473-478 (2002). (Pubitemid 34847327)
42. Foley JE, Clueit SB, Brown RN. Differential exposure to Anaplasma phagocytophilum in rodent species in northern California. Vector Borne Zoonotic Dis. 8(1), 49-55 (2008). (Pubitemid 351271599)
43. Adamska M, Skotarczak B. Wild game as a reservoir of Anaplasma phagocytophilum in north-western Poland. Wiad. Parazytol. 53(2), 103-107 (2007).
44. de la Fuente J, Ruiz-Fons F, Naranjo V, Torina A, Rodriguez O, Gortazar C. Evidence of Anaplasma infections in European roe deer (Capreolus capreolus) from southern Spain. Res. Vet. Sci. 84(3), 382-386 (2008). (Pubitemid 351486854)
45. Torina A, Vicente J, Alongi A et al. Observed prevalence of tick-borne pathogens in domestic animals in Sicily, Italy during 2003-2005. Zoonoses Public Health 54(1), 8-15 (2007).
46. Grzeszczuk A, Karbowiak G, Ziarko S, Kovalchuk O. The root-vole Microtus oeconomus (Pallas, 1776): a new potential reservoir of Anaplasma phagocytophilum. Vector Borne Zoonotic Dis. 6(3), 240-243 (2006). (Pubitemid 44793597)
47. Massung RF, Courtney JW, Hiratzka SL, Pitzer VE, Smith G, Dryden RL. Anaplasma phagocytophilum in white-tailed deer. Emerg. Infect. Dis. 11(10), 1604-1606 (2005). (Pubitemid 41384351)
48. Silaghi C, Gilles J, Hohle M, Fingerle V, Just FT, Pfster K. Anaplasma phagocytophilum infection in Ixodes ricinus, Bavaria, Germany. Emerg. Infect. Dis. 14(6), 972-974 (2008). (Pubitemid 351838615)
49. Massung RF, Levin ML, Miller NJ, Mather TN. Reservoir competency of goats for Anaplasma phagocytophilum. Ann. NY Acad. Sci. 1078, 476-478 (2006). (Pubitemid 44968661)
50. Paulauskas A, Radzijevskaja J, Rosef O. Anaplasma in ticks feeding on migrating birds and questing ticks in Lithuania and Norway. Clin. Microbiol. Infect. (2009) (Epub ahead of print).
51. Santos-Silva MM, Sousa R, Santos AS, Melo P, Encarnacao V, Bacellar F. Ticks parasitizing wild birds in Portugal: detection of Rickettsia aeschlimannii R. helvetica and R. massiliae. Exp. Appl. Acarol. 39(3-4), 331-338 (2006). (Pubitemid 44273043)
52. Daniels TJ, Battaly GR, Liveris D, Falco RC, Schwartz I. Avian reservoirs of the agent of human granulocytic ehrlichiosis? Emerg. Infect. Dis. 8(12), 1524-1525 (2002). (Pubitemid 36013432)
53. Blanco JR, Oteo JA. Human granulocytic ehrlichiosis in Europe. Clin. Microbiol. Infect. 8(12), 763-772 (2002).
54. Dumler JS. Anaplasma and Ehrlichia infection. Ann. NY Acad. Sci. 1063, 361-373 (2005).
55. Petrovec M, Lotric FS, Zupanc TA et al. Human disease in Europe caused by a granulocytic Ehrlichia species. J. Clin. Microbiol. 35(6), 1556-1559 (1997). (Pubitemid 27216832)
56. Lotric-Furlan S, Petrovec M, Avsic-Zupanc T et al. Human ehrlichiosis in central Europe. Wien. Klin. Wochenschr. 110(24), 894-897 (1998). (Pubitemid 29067794)
57. Lotric-Furlan S, Petrovec M, Zupanc TA et al. Human granulocytic ehrlichiosis in Europe: clinical and laboratory fndings for four patients from Slovenia. Clin. Infect. Dis. 27(3), 424-428 (1998). (Pubitemid 28421984)
58. van Dobbenburgh A, van Dam AP, Fikrig E. Human granulocytic ehrlichiosis in western Europe. N. Engl. J. Med. 340(15), 1214-1216 (1999). (Pubitemid 29177888)
59. von Loewenich FD, Stumpf G, Baumgarten BU, Rollinghoff M, Dumler JS, Bogdan C. Human granulocytic ehrlichiosis in Germany: evidence from serological studies, tick analyses, and a case of equine ehrlichiosis. Ann. NY Acad. Sci. 990, 116-117 (2003). (Pubitemid 36814021)
60. Fingerle V, Goodman JL, Johnson RC, Kurtti TJ, Munderloh UG, Wilske B. Epidemiological aspects of human granulocytic ehrlichiosis in southern Germany. Wien. Klin. Wochenschr. 111(22-23), 1000-1004 (1999). (Pubitemid 30026425)
61. Parola P, Davoust B, Raoult D. Tick-and fea-borne rickettsial emerging zoonoses. Vet. Res. 36(3), 469-492 (2005). (Pubitemid 40718654)
62. Amiel C, Abadia G, Choudat D. Human granulocytic ehrlichiosis in Europe. Med. Mal. Infect. 34(3), 111-122 (2004). (Pubitemid 38326677)
63. Lillini E, Macri G, Proietti G, Scarpulla M. New fndings on anaplasmosis caused by infection with Anaplasma phagocytophilum. Ann. NY Acad. Sci. 1081, 360-370 (2006). (Pubitemid 46001351)
64. Ruscio M, Cinco M. Human granulocytic ehrlichiosis in Italy: first report on two confrmed cases. Ann. NY Acad. Sci. 990, 350-352 (2003). (Pubitemid 36814025)
65. Oteo JA, Gil H, Barral M et al. Presence of granulocytic ehrlichia in ticks and serological evidence of human infection in La Rioja, Spain. Epidemiol. Infect. 127(2), 353-358 (2001). (Pubitemid 33019548)
66. Oteo JA, Blanco JR, Martínez de Artola V, Ibarra V. First report of human granulocytic ehrlichiosis from southern Europe (Spain). Emerg. Infect. Dis. 6(4), 430-432 (2000). (Pubitemid 30643675)
67. Bjoersdorff A, Wittesjo B, Berglun J, Massung RF, Eliasson I. Human granulocytic ehrlichiosis as a common cause of tick-associated fever in Southeast Sweden: report from a prospective clinical study. Scand. J. Infect. Dis. 34(3), 187-191 (2002). (Pubitemid 34303057)
68. Karlsson U, Bjoersdorff A, Massung RF, Christensson B. Human granulocytic ehrlichiosis-a clinical case in Scandinavia. Scand. J. Infect. Dis. 33(1), 73-74 (2001). (Pubitemid 32156735)
69. Kristiansen BE, Jenkins A, Tveten Y, Karsten B, Line O, Bjoersdorff A. Human granulocytic ehrlichiosis in Norway. Tidsskr. Nor Laegeforen. 121(7), 805-806 (2001). (Pubitemid 33708085)
70. Bakken JS, Krueth J, Tilden RL, Dumler JS, Kristiansen BE. Serological evidence of human granulocytic ehrlichiosis in Norway. Eur. J. Clin. Microbiol. Infect. Dis. 15(10), 829-832 (1996). (Pubitemid 26386130)
71. Walder G, Tiwald G, Dierich MP, Wurzner R. Serological evidence for human granulocytic ehrlichiosis in Western Austria. Eur. J. Clin. Microbiol. Infect. Dis. 22(9), 543-547 (2003). (Pubitemid 37214029)
72. Walder G, Falkensammer B, Aigner J et al. First documented case of human granulocytic ehrlichiosis in Austria. Wien. Klin. Wochenschr. 115(7-8), 263-266 (2003). (Pubitemid 36755242)
73. Brouqui P, Dumler JS, Lienhard R, Brossard M, Raoult D. Human granulocytic ehrlichiosis in Europe. Lancet 346(8977), 782-783 (1995).
74. Pusterla N, Weber R, Wolfensberger C et al. Serological evidence of human granulocytic ehrlichiosis in Switzerland. Eur. J. Clin. Microbiol. Infect. Dis. 17(3), 207-209 (1998). (Pubitemid 28306271)
75. Daniel SA, Manika K, Arvanitidou M, Diza E, Symeonidis N, Antoniadis A. Serologic evidence of human granulocytic ehrlichiosis, Greece. Emerg. Infect. Dis. 8(6), 643-644 (2002). (Pubitemid 34556370)
76. Zwolinski J, Chmielewska-Badora J, Cisak E, Buczek A, Dutkiewicz J. Prevalence of antibodies to Anaplasma phagocytophilum and Borrelia burgdorferi in forestry workers from the Lublin region. Wiad. Parazytol. 50(2), 221-227 (2004).
77. Tylewska-Wierzbanowska S, Chmielewski T, Kondrusik M, Hermanowska-Szpakowicz T, Sawicki W, Sulek K. First cases of acute human granulocytic ehrlichiosis in Poland. Eur. J. Clin. Microbiol. Infect. Dis. 20(3), 196-198 (2001). (Pubitemid 32375133)
78. Heyman P, Cochez C, Bigaignon G, Guillaume B, Zizi M, Vandenvelde C. Human granulocytic ehrlichiosis in Belgium: an underestimated cause of disease. J. Infect. 47(2), 129-132 (2003). (Pubitemid 36896395)
79. Guillaume B, Heyman P, Lafontaine S, Vandenvelde C, Delmee M, Bigaignon G. Seroprevalence of human granulocytic ehrlichiosis infection in Belgium. Eur. J. Clin. Microbiol. Infect. Dis. 21(5), 397-400 (2002). (Pubitemid 34810678)
80. Dumler JS, Bakken JS. Human granulocytic ehrlichiosis in Wisconsin and Minnesota: a frequent infection with the potential for persistence. J. Infect. Dis. 173(4), 1027-1030 (1996). (Pubitemid 26001191)
81. Wormser GP, Dattwyler RJ, Shapiro ED et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 43(9), 1089-1134 (2006). (Pubitemid 44637131)
82. Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin. Infect. Dis. 31(2), 554-560 (2000). (Pubitemid 32289590)
83. Weber K, Schierz G, Wilske B, Preac-Mursic V. European erythema migrans disease and related disorders. Yale J. Biol Med. 57(4), 463-471 (1984). (Pubitemid 15151031)
84. Steere AC, Malawista SE, Snydman DR et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. Arthritis Rheum. 20(1), 7-17 (1977).
85. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease-a tick-borne spirochetosis? Science 216(4552), 1317-1319 (1982).
86. Steere AC, Grodzicki RL, Kornblatt AN et al. The spirochetal etiology of Lyme disease. N. Engl. J. Med. 308(13), 733-740 (1983). (Pubitemid 13158637)
87. Steere AC. Lyme disease. N. Engl. J. Med. 345(2), 115-125 (2001). (Pubitemid 32640193)
88. Stanek G, Strle F. Lyme disease: European perspective. Infect. Dis. Clin. North Am. 22(2), 327-339, vii (2008).
89. Stanek G, Strle F. Lyme borreliosis: a European perspective on diagnosis and clinical management. Curr. Opin. Infect. Dis. 22(5), 450-454 (2009).
90. Brouqui P, Bacellar F, Baranton G et al. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin. Microbiol. Infect. 10(12), 1108-1132 (2004). (Pubitemid 40050854)
91. Baker PJ. Perspectives on 'chronic Lyme disease'. Am. J. Med. 121(7), 562-564 (2008).
92. Fingerle V, Schulte-Spechtel UC, Ruzic-Sabljic E et al. Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int. J. Med. Microbiol. 298(3-4), 279-290 (2008). (Pubitemid 351318362)
93. Rudenko N, Golovchenko M, Ruzek D, Piskunova N, Mallatova N, Grubhoffer L. Molecular detection of Borrelia bissettii DNA in serum samples from patients in the Czech Republic with suspected borreliosis. FEMS Microbiol. Lett. 292(2), 274-281 (2009).
94. Hugli D, Moret J, Rais O et al. Tick bites in a Lyme borreliosis highly endemic area in Switzerland. Int. J. Med. Microbiol. 299(2), 155-160 (2009).
95. Robertson JN, Gray JS, Stewart P. Tick bite and Lyme borreliosis risk at a recreational site in England. Eur. J. Epidemiol. 16(7), 647-652 (2000).
96. Gern L. Borrelia burgdorferi sensu lato, the agent of lyme borreliosis: life in the wilds. Parasite 15(3), 244-247 (2008).
97. Rauter C, Hartung T. Prevalence of Borrelia burgdorferi sensu lato genospecies in Ixodes ricinus ticks in Europe: a metaanalysis. Appl. Environ. Microbiol. 71(11), 7203-7216 (2005). (Pubitemid 43194214)
98. Lindgren E, Jaenson TG. Lyme borreliosis in Europe: infuences of climate change, epidemiology, ecology and adaptation measures. EUR/04/5046250 (2006).
99. Gray JS, Dautel H, Estrada-Pena A, Kahl O, Lindgren E. Effects of climate change on ticks and tick-borne diseases in Europe. Interdiscip. Perspect. Infect. Dis. 2009, 593232 (2009).
100. Smith R, Takkinen J. Lyme borreliosis: Europe-wide coordinated surveillance and action needed? Euro. Surveill. 11(6), E060622.1 (2006).
101. European Union Concerted Action on Lyme Borreliosis, EUCALB (2008).
102. Lopes de Carvalho I, Núncio MS. Laboratory diagnosis of Lyme borreliosis at the Portuguese National Institute of Health (1990-2004). Euro. Surveill. 11(10), 257-260 (2006).
103. Piesman J, Dolan MC. Protection against lyme disease spirochete transmission provided by prompt removal of nymphal Ixodes scapularis (Acari: Ixodidae). J. Med. Entomol. 39(3), 509-512 (2002). (Pubitemid 135700286)
104. Corapi KM, White MI, Phillips CB, Daltroy LH, Shadick NA, Liang MH. Strategies for primary and secondary prevention of Lyme disease. Nat. Clin. Pract. Rheumatol. 3(1), 20-25 (2007).
105. Clark R P, Hu LT. Prevention of lyme disease and other tick-borne infections. Infect. Dis. Clin. North Am. 22(3), 381-396, vii (2008).
106. Robinson D, Leo N, Prociv P, Barker SC. Potential role of head lice, Pediculus humanus capitis, as vectors of Rickettsia prowazekii. Parasitol. Res. 90(3), 209-211 (2003). (Pubitemid 36819140)
107. Parola P, Paddock CD, Raoult D. Tick-borne rickettsioses around the world: emerging diseases challenging old concepts. Clin. Microbiol. Rev. 18(4), 719-756 (2005). (Pubitemid 41504513)
108. de Sousa R, Nobrega SD, Bacellar F, Torgal J. Mediterranean spotted fever in Portugal: risk factors for fatal outcome in 105 hospitalized patients. Ann. NY Acad. Sci. 990, 285-294 (2003). (Pubitemid 36808315)
109. Eremeeva ME, Dasch GA. Closing the gaps between genotype and phenotype in Rickettsia rickettsii. Ann. NY Acad. Sci. 1166, 12-26 (2009).
110. Karpathy SE, Dasch GA, Eremeeva ME. Molecular typing of isolates of Rickettsia rickettsii by use of DNA sequencing of variable intergenic regions. J. Clin. Microbiol. 45(8), 2545-2553 (2007). (Pubitemid 47295486)
111. Dantas-Torres F. Rocky Mountain spotted fever. Lancet Infect. Dis. 7(11), 724-732 (2007). (Pubitemid 47603231)
112. Rovery C, Brouqui P, Raoult D. Questions on Mediterranean spotted fever a Century after its discovery. Emerg. Infect. Dis. 14(9), 1360-1367 (2008).
113. Jones KE, Patel NG, Levy MA et al. Global trends in emerging infectious diseases. Nature 451(7181), 990-993 (2008). (Pubitemid 351301726)
114. Brouqui P, Parola P, Fournier PE, Raoult D. Spotted fever rickettsioses in southern and eastern Europe. FEMS Immunol. Med. Microbiol. 49(1), 2-12 (2007). (Pubitemid 46160580)
115. Parola P, Socolovschi C, Jeanjean L et al. Warmer weather linked to tick attack and emergence of severe rickettsioses. PLoS Negl. Trop. Dis. 2(11), e338 (2008).
116. Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature 430(6996), 242-249 (2004). (Pubitemid 38902437)
117. Jensenius M, Parola P, Raoult D. Threats to international travellers posed by tick-borne diseases. Travel Med. Infect. Dis. 4(1), 4-13 (2006). (Pubitemid 43193272)
118. Parola P, Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin. Infect. Dis. 32(6), 897-928 (2001). (Pubitemid 32524824)
119. Raoult D, Lakos A, Fenollar F, Beytout J, Brouqui P, Fournier PE. Spotless rickettsiosis caused by Rickettsia slovaca and associated with Dermacentor ticks. Clin. Infect. Dis. 34(10), 1331-1336 (2002). (Pubitemid 34507942)
120. Macaluso KR, Sonenshine DE, Ceraul SM, Azad AF. Rickettsial infection in Dermacentor variabilis (Acari: Ixodidae) inhibits transovarial transmission of a second Rickettsia. J. Med. Entomol. 39(6), 809-813 (2002). (Pubitemid 135693334)
121. Socolovschi C, Huynh TP, Davoust B, Gomez J, Raoult D, Parola P. Transovarial and trans-stadial transmission of Rickettsiae africae in Amblyomma variegatum ticks. Clin. Microbiol. Infect. (2009) (Epub ahead of print).
122. Walker DH. Tick-transmitted infectious diseases in the United States. Annu. Rev. Public Health 19, 237-269 (1998). (Pubitemid 28279931)
123. Mylonakis E. When to suspect and how to monitor babesiosis. Am. Fam. Physician 63(10), 1969-1974 (2001). (Pubitemid 32493209)
124. Bock R, Jackson L, de Vos A, Jorgensen W. Babesiosis of cattle. Parasitology 129(Suppl.), S247-S269 (2004). (Pubitemid 40780698)
125. Criado-Fornelio A, Buling A, Pingret JL et al. Hemoprotozoa of domestic animals in France: prevalence and molecular characterization. Vet. Parasitol. 159(1), 73-76 (2009).
126. Devos J, Geysen D. Epidemiological study of the prevalence of Babesia divergens in a veterinary practice in the mid-east of France. Vet. Parasitol. 125(3-4), 237-249 (2004). (Pubitemid 39346397)
127. Gray JS. Identity of the causal agents of human babesiosis in Europe. Int. J. Med. Microbiol. 296(Suppl. 40), 131-136 (2006).
128. Zintl A, Gray JS, Skerrett HE, Mulcahy G. Possible mechanisms underlying age-related resistance to bovine babesiosis. Parasite Immunol. 27(4), 115-120 (2005). (Pubitemid 40806800)
129. Hunfeld KP, Hildebrandt A, Gray JS. Babesiosis: recent insights into an ancient disease. Int. J. Parasitol. 38(11), 1219-1237 (2008).
130. Uilenberg G. Babesia-a historical overview. Vet. Parasitol. 138(1-2), 3-10 (2006). (Pubitemid 44275258)
131. Saegerman C, Claes L, Dewaele A et al Differential diagnosis of neurologically expressed disorders in Western European cattle. Rev. Sci. Tech. 22(1), 83-102 (2003).
132. Holman PJ, Spencer AM, Telford SR III et al. Comparative infectivity of Babesia divergens and a zoonotic Babesia divergens-like parasite in cattle. Am. J. Trop. Med. Hyg 73(5), 865-870 (2005). (Pubitemid 41688460)
133. Zintl A, Mulcahy G, Skerrett HE, Taylor SM, Gray JS. Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin. Microbiol. Rev. 16(4), 622-636 (2003). (Pubitemid 37303912)
134. Kjemtrup AM, Conrad PA. Human babesiosis: an emerging tick-borne disease. Int. J. Parasitol. 30(12-13), 1323-1337 (2000).
135. L'Hostis M, Chauvin A, Valentin A, Marchand A, Gorenfot A. Large scale survey of bovine babesiosis due to Babesia divergens in France. Vet. Rec. 136(2), 36-38 (1995).
136. Homer MJ, Aguilar-Delfn I, Telford SR III, Krause PJ, Persing DH. Babesiosis. Clin. Microbiol. Rev. 13(3), 451-469 (2000). (Pubitemid 30452617)
137. Leiby DA. Babesiosis and blood transfusion: fying under the radar. Vox Sang. 90(3), 157-165 (2006).
138. L'Hostis M, Bureaud A, Gorenfot A. Female Ixodes ricinus (Acari, Ixodidae) in cattle of western France: infestation level and seasonality. Vet. Res. 27(6), 589-597 (1996). (Pubitemid 126515482)
139. L'Hostis M, Seegers H. Tick-borne parasitic diseases in cattle: current knowledge and prospective risk analysis related to the ongoing evolution in French cattle farming systems. Vet. Res. 33(5), 599-611 (2002). (Pubitemid 35157735)
140. Chauvin A, Moreau E, Bonnet S, Plantard O, Malandrin L. Babesia and its hosts: adaptation to long-lasting interactions as a way to achieve effcient transmission. Vet. Res. 40(2), 37 (2009).
141. L'Hostis M, Chauvin A, Valentin A, Precigout E, Gorenfot A. Survey of Babesia divergens antibody kinetics in cattle in western France. Vet. Res. 28(5), 481-488 (1997). (Pubitemid 127521318)
142. Wielinga PR, Fonville M, Sprong H, Gaasenbeek C, Borgsteede F, Giessen JW. Persistent detection of Babesia EU1 and Babesia microti in Ixodes ricinus in The Netherlands during a 5-year surveillance: 2003-2007. Vector Borne Zoonotic Dis. (2008) (Epub ahead of print).
143. Hoby S, Mathis A, Doherr MG, Robert N, Ryser-Degiorgis MP. Babesia capreoli infections in alpine chamois (rupicapra R. Rupicapra), roe deer (Capreolus C. Capreolus) and red deer (Cervus elaphus) from Switzerland. J. Wildl. Dis. 45(3), 748-763 (2009).
144. Yin H, Lu W, Luo J, Zhang Q, Lu W, Dou H. Experiments on the transmission of Babesia major and Babesia bigemina by Haemaphysalis punctata. Vet. Parasitol. 67(1-2), 89-98 (1996). (Pubitemid 27059734)
145. Cunha BA, Cohen YZ, McDermott B. Fever of unknown origin (FUO) due to babesiosis in a immunocompetent host. Heart Lung 37(6), 481-484 (2008).
146. Thiel HJ, Collett MS, Gould EA et al. Flaviviridae. In: Virus Taxonomy: Classifcation and Nomenclature, Eighth Report of the International Committee on the Taxonomy of Viruses. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA (Eds). Elsevier Academic Press, Amsterdam, The Netherlands, 981-998 (2005).
147. Gritsun TS, Lashkevich VA, Gould EA. Tick-borne encephalitis. Antiviral Res. 57(1-2), 129-146 (2003). (Pubitemid 36254727)
148. Charrel RN, Attoui H, Butenko AM et al. Tick-borne virus diseases of human interest in Europe. Clin. Microbiol. Infect. 10(12), 1040-1055 (2004). (Pubitemid 40044976)
149. Rampas J, Gallia F. Isolation of tick-borne encephalitis virus from ticks Ixodes ricinus. Èas. Lék. Èes. 88, 1179-1180 (1949).
150. Gritsun TS, Frolova T V, Zhankov AI et al. Characterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis. J. Virol. 77(1), 25-36 (2003). (Pubitemid 36004943)
151. Suss J. Epidemiology and ecology of TBE relevant to the production of effective vaccines. Vaccine 21(Suppl. 1), S19-S35 (2003).
152. Golovljova I, Vene S, Sjolander KB, Vasilenko V, Plyusnin A, Lundkvist A. Characterization of tick-borne encephalitis virus from Estonia. J. Med. Virol. 74(4), 580-588 (2004). (Pubitemid 39426099)
153. Gresikova M, Noseck J. Isolation of tick-borne encephalitis virus from Haemaphysalis inermis ticks. Acta Virol. 10(4), 359-361 (1966).
154. Gresikova M, Kaluzova M. Biology of tick-borne encephalitis virus. Acta Virol. 41(2), 115-124 (1997). (Pubitemid 27462841)
155. Krivanec K, Kopecky J, Tomkova E, Grubhoffer L. Isolation of TBE virus from the tick Ixodes hexagonus. Folia Parasitol. (Praha) 35(3), 273-276 (1988).
156. Zlobin VI, Gorin OZ. Tick-Borne Encephalitis: Etiology, Epidemiology and Prophylactics in Siberia. Philippova LB (Eds). Nauka, Novosibirsk, Russia, 177 (1996) (In Russian).
157. Labuda M, Randolph SE. Survival strategy of tick-borne encephalitis virus: cellular basis and environmental determinants. Zentralbl. Bakteriol. 289(5-7), 513-524 (1999). (Pubitemid 30047244)
158. Pavlovskij EN. On natural focality of infectious and parasitic diseases. Vestn. Akad. Nauk. SSSR 10, 98-108 (1939).
159. Nuttall PA, Labuda M. Dynamics of infection in tick vectors and at the tick-host interface. Adv. Virus Res. 60, 233-272 (2003). (Pubitemid 137640953)
160. Kozuch O, Nosek J, Chmela J, Ernek E, Uvizl M, Bolek S. The ecology if the virus of tick-borne encephalitis in the natural foci in the Olomouc district (author's transl). Cesk. Epidemiol. Mikrobiol. Imunol. 25(2), 88-96 (1976).
161. International Catalogue of Arboviruses. 3rd Edition. Karabatsos N (Eds). American Society of Tropical Medicine and Hygiene, San Antonio, TX, USA (1985).
162. Labuda M, Austyn JM, Zuffova E et al. Importance of localized skin infection in tick-borne encephalitis virus transmission. Virology 219(2), 357-366 (1996). (Pubitemid 26188386)
163. Schneider H. Über epidemische akute, Meningitis serosa. Wien Klin. Woch. 44, 350-352 (1931).
164. Zilber LA. Spring (spring-summer) epidemical tick-borne encephalitis. Arch. Biol. Nauk. 56, 9-37 (1939).
165. Oker-Blom N. Kumlinge disease; a meningo-encephalitis occuring in the Aaland Islands. Ann. Med. Exp. Biol. Fenn. 34, 309-318 (1956).
166. Gallia Feal. Laboratory infection caused by tick-borne encephaltis virus. Cas. Lék. Ces. 88, 224-229 (1949).
167. Krejcí J. Isolement d'un virus noveau en course d'un epidémie de meningoencephalite dans la region de Vykov (Moraviae). Presse Méd.(Paris) 74, 1084 (1949).
168. Krejcí J. Epidemie virusových encefalitid na Vykovsku. Lék. Listy (Brno) 4, 73-134 (1949).
169. Nuttall PA, Labuda M. Tick-borne encephalitides. In: Zoonoses: Biology, Clinical Practice, and Public Health Control Palmer SR, Lord Soulsby, Simpson DIH (Eds). Oxford University Press, Oxford, UK, 469-486 (1998).
170. Jaenson TG, Talleklint L, Lundqvist L, Olsen B, Chirico J, Mejlon H. Geographical distribution, host associations, and vector roles of ticks (Acari: Ixodidae, Argasidae) in Sweden. J. Med. Entomol. 31(2), 240-256 (1994). (Pubitemid 2052425)
171. Haglund M, Vene S, Forsgren M et al Characterisation of human tick-borne encephalitis virus from Sweden. J. Med. Virol. 71(4), 610-621 (2003). (Pubitemid 37309935)
172. Bormane A, Lucenko I, Duks A et al. Vectors of tick-borne diseases and epidemiological situation in Latvia in 1993-2002. Int. J. Med. Microbiol 293(Suppl. 37), 36-47 (2004). (Pubitemid 38962768)
173. Suss J. Tick-borne encephalitis in Europe and beyond-the epidemiological situation as of 2007. Euro. Surveill. 13(26), pii: 18916 (2008).
174. Donoso MO, Schadler R, Niedrig M. A survey on cases of tick-borne encephalitis in European countries. Euro. Surveill 13(17), pii: 18848 (2008).
175. Bröker M. Frühsommermeningoenzephalitis (FSME) in Ostasien. Impf Dialog 2, 52-55 (2008).
176. Bröker M, Gniel D. New foci of tick-borne encephalitis virus in Europe: consequences for travellers from abroad. Travel Med. Infect. Dis. 1, 181-184 (2003) (Pubitemid 40432874)
177. Pogodina V V, Bochkova NG, Karan' LS et al. Comparative analysis of virulence of the Siberian and Far-East subtypes of the tick-born encephalitis virus. Vopr. Virusol. 49(6), 24-30 (2004). (Pubitemid 39626463)
178. Voronkova GM, Zakharycheva TA. The condition of tick-borne infections problem in Khabarovsk region. Bulletin SORAMN 4, 82-88 (2007).
179. Votyakov VI, Zlobin VI, Mishaeva NP Tick-Borne Encephalitis of Eurasia. Nauka, Novosibirsk, Russia (2002) (In Russian).
180. Mansfeld KL, Johnson N, Phipps LP, Stephenson JR, Fooks AR, Solomon T Tick-borne encephalitis-a review of an emerging zoonosis. J. Gen. Virol. 90, 1781-1794 (2009).
181. Donoso MO, Achazi K, Niedrig M. Serology versus PCR methods for the detection of tick-borne encephalitis virus infections in humans. Future Virol. 2, 565-572 (2007). (Pubitemid 350142075)
182. Dumpis U, Crook D, Oksi J. Tick-borne encephalitis. Clin. Infect. Dis. 28(4), 882-890 (1999). (Pubitemid 29169431)
183. Poponnikova TV. Specifc clinical and epidemiological features of tick-borne encephalitis in Western Siberia. Int. J. Med. Microbiol. 296(S), 59-62 (2006). (Pubitemid 43668604)
184. Gunther G, Haglund M, Lindquist L, Forsgren M, Skoldenberg B. Tick-borne encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: a prospective study of clinical course and outcome. J. Neurol. 244(4), 230-238 (1997). (Pubitemid 27156472)
185. Kaiser R. The clinical and epidemiological profle of tick-borne encephalitis in southern Germany 1994-1998: a prospective study of 656 patients. Brain 122(Pt 11), 2067-2078 (1999).
186. Holzmann H. Diagnosis of tick-borne encephalitis. Vaccine 21(S), 36-40 (2003).
187. Gustafson R, Svenungsson B, Forsgren M, Gardulf A, Granstrom M. Two-year survey of the incidence of Lyme borreliosis and tick-borne encephalitis in a high-risk population in Sweden. Eur. J. Clin. Microbiol. Infect. Dis. 11(10), 894-900 (1992). (Pubitemid 23011896)
188. Lindquist L, Vapalahti O. Tick-borne encephalitis. Lancet 371(9627), 1861-1871 (2008). (Pubitemid 351753031)
189. Mickiene A, Laiskonis A, Gunther G, Vene S, Lundkvist A, Lindquist L. Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosis. Clin. Infect. Dis. 35(6), 650-658 (2002). (Pubitemid 35024723)
190. Kaiser R, Holzmann H. Laboratory fndings in tick-borne encephalitis-correlation with clinical outcome. Infection 28, 78-84 (2000). (Pubitemid 30189612)
191. Toporkova MG, Aleshin SE, Ozherelkov SV, Nadezdina M V, Stephenson J, Timofeev AV. Serum levels of interleukin 6 in recently hospitalized tick-borne encephalitis patients correlate with age, but not with disease outcome. Clin. Exp. Immunol. 152, 517-521 (2008). (Pubitemid 351661490)
192. + T-cells mediate immunolopathology in tick-borne encephalitis. Virology 384(1), 1-6 (2009).
193. Jones N, Sperl W, Koch J, Holzmann H, Radauer W. Tick-borne encephalitis in a 17-day-old newborn resulting in severe neurologic impairment. Pediatr. Infect. Dis. J. 26(2), 185-186 (2007). (Pubitemid 46183374)
194. Waldvogel K, Bossart W, Huisman T, Boltshauser E, Nadal D. Severe tick-borne encephalitis following passive immunization. Eur. J. Pediatr. 155(9), 775-779 (1996). (Pubitemid 26261870)
195. Rendi-Wagner P. Advances in vaccination against tick-borne encephalitis virus. Expert Rev. Vaccines 7, 589-596 (2008). (Pubitemid 351881343)
196. Hayasaka D, Goto A, Yoshii K, Mizutani T, Kariwa H, Takashima I. Evaluation of European tick-borne encephalitis vaccine against recent Siberian and far-eastern strains. Vaccine 19, 4774-4779 (2001). (Pubitemid 32800763)
197. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 6(4), 203-214 (2006).
198. Chumakov MP. A new virus-Crimean hemorrhagic fever (in Russian). Nov. Med. 4, 9-11 (1949).
199. Simpson DI, Knight EM, Courtois G, Williams MC, Weinbren MP, Kibukamusoke JW Congo virus: a hitherto undescribed virus occurring in Africa. I. Human isolations-clinical notes. East Afr. Med. J. 44(2), 86-92 (1967).
200. Casals J. Antigenic similarity between the virus causing Crimean hemorrhagic fever and Congo virus. Proc. Soc. Exp. Biol. Med 131(1), 233-236 (1969).
201. Schmaljohn CS, Nichol ST. Bunyaviridae. In: Fields Virology. Knipe DM, Howley PM (Eds). Lippincott, Williams and Wilkins, PA, USA, 1741-1789 (2007).
202. Papa A, Bozovi B, Pavlidou V, Papadimitriou E, Pelemis M, Antoniadis A. Genetic detection and isolation of Crimean-Congo hemorrhagic fever virus, Kosovo, Yugoslavia. Emerg. Infect. Dis. 8(8), 852-854 (2002).
203. Fisher-Hoch SP, Khan JA, Rehman S, Mirza S, Khurshid M, McCormick JB. Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet 346(8973), 472-475 (1995).
204. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J. Med. Entomol. 15(4), 307-417 (1979).
205. Swanepoel R, Shepherd AJ, Leman PA et al Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa. Am. J. Trop. Med. Hyg 36(1), 120-132 (1987). (Pubitemid 17033988)
206. Duh D, Saksida A, Petrovec M et al. Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg. Infect. Dis. 13(11), 1769-1772 (2007). (Pubitemid 350126211)
207. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin. Microbiol. Infect. 12(6), 551-554 (2006). (Pubitemid 43740766)
208. Ergonul O. Clinical and Pathological Features of Crimean-Congo Hemorrhagic Fever. Ergonul O, Whitehouse CA (Eds). Springer, Dordrecht, The Netherlands, 207-220 (2007).
209. Papa A, Drosten C, Bino S et al. Viral load and Crimean-Congo hemorrhagic fever. Emerg. Infect. Dis. 13(5), 805-806 (2007). (Pubitemid 46698764)
210. Papa A, Dalla VG, Papadimitriou E, Kartalis GN, Antoniadis A. Emergence of Crimean-Congo haemorrhagic fever in Greece. Clin. Microbiol. Infect. (2009) (Epub ahead of print).
211. Karti SS, Odabasi Z, Korten V et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg. Infect. Dis. 10(8), 1379-1384 (2004). (Pubitemid 39014149)
212. Cagatay A, Kapmaz M, Karadeniz A et al. Haemophagocytosis in a patient with Crimean Congo haemorrhagic fever. J. Med. Microbiol. 56(Pt 8), 1126-1128 (2007). (Pubitemid 47262681)
213. Yilmaz M, Aydin K, Akdogan E et al. Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever. J. Clin. Virol. 42(4), 415-417 (2008).
214. Burt FJ, Swanepoel R, Shieh WJ et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch. Pathol. Lab. Med. 121(8), 839-846 (1997). (Pubitemid 27357578)
215. Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J. Clin. Virol. 36(4), 272-276 (2006). (Pubitemid 44066895)
216. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-a in patients with Crimean-Congo hemorrhagic fever. J. Infect. Dis. 193(7), 941-944 (2006).
217. Weber F, Mirazimi A. Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis. Cytokine Growth Factor Rev. 19(5-6), 395-404 (2008).
218. Andersson I, Karlberg H, Mousavi-Jazi M, Martinez-Sobrido L, Weber F, Mirazimi A. Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response. J. Med. Virol. 80(8), 1397-1404 (2008). (Pubitemid 351897412)
219. Connolly-Andersena AM, Douagib I, Krausa AA, Mirazimia A. Crimean-Congo haemorrhagic fever virus infects human monocyte-derived dendritic cells. Virology 390(2), 157-162 (2009).
220. Burt FJ, Leman PA, Abbott JC, Swanepoel R. Serodiagnosis of Crimean-Congo haemorrhagic fever. Epidemiol. Infect. 113(3), 551-562 (1994).
221. Schwarz TF, Nsanze H, Longson M et al. Polymerase chain reaction for diagnosis and identifcation of distinct variants of Crimean-Congo hemorrhagic fever virus in the United Arab Emirates. Am. J. Trop. Med. Hyg. 55(2), 190-196 (1996). (Pubitemid 26299205)
222. Zeller H. Laboratory diagnosis of Crimean-Congo haemorrhagic fever. In: Crimean Congo Haemorrhagic Fever. A Global perspective. Ergonul O, Whitehouse CA (Eds). Springer, Dordrecht, The Netherlands, 233-243 (2007).
223. Yapar M, Aydogan H, Pahsa A et al. Rapid and quantitative detection of Crimean-Congo hemorrhagic fever virus by one-step real-time reverse transcriptase-PCR. Jpn. J. Infect. Dis. 58(6), 358-362 (2005). (Pubitemid 43078733)
224. Wolfel R, Paweska JT, Petersen N et al. Low-density macroarray for rapid detection and identifcation of Crimean-Congo hemorrhagic fever virus. J. Clin. Microbiol. 47(4), 1025-1030 (2009).
225. Papa A, Bino S, Papadimitriou E, Velo E, Dhimolea M, Antoniadis A. Suspected Crimean Congo haemorrhagic fever cases in Albania. Scand. J. Infect. Dis. 40(11-12), 978-980 (2008).
226. Tasdelen FN, Fisgin T, Tanyel E et al. Crimean-Congo hemorrhagic fever: five patients with hemophagocytic syndrome. Am.J Hematol. 83(1), 73-76 (2008).
227. Ergonul O. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res. 78(1), 125-131 (2008).
228. Elaldi N, Bodur H, Ascioglu S et al. Effcacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J. Infect. 58(3), 238-244 (2009).
229. Vassilenko SM, Vassilev TL, Bozadjiev LG, Bineva IL, Kazarov GZ. Specifc intravenous immunoglobulin for Crimean-Congo haemorrhagic fever. Lancet 335(8692), 791-792 (1990). (Pubitemid 20106716)
230. Papa A, Christova I, Papadimitriou E, Antoniadis A. Crimean-Congo hemorrhagic fever in Bulgaria. Emerg. Infect. Dis. 10(8), 1465-1467 (2004). (Pubitemid 39014162)
231. Maltezou HC, Papa A, Tsiodras S, Dalla V, Maltezos E, Antoniadis A. Crimean-Congo hemorrhagic fever in Greece: a public health perspective. Int. J. Infect. Dis. 13(6), 713-716. (2009).
232. Christova I, Di Caro A, Papa A et al. Crimean-Congo hemorrhagic fever, southwestern Bulgaria. Emerg. Infect. Dis. 15(6), 983-985 (2009).
233. Duh D, Saksida A, Petrovec M, Dedushaj I, Avsic-Zupanc T. Novel one-step real-time RT-PCR assay for rapid and specifc diagnosis of Crimean-Congo hemorrhagic fever encountered in the Balkans. J. Virol. Methods 133(2), 175-179 (2006).
234. Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J. Med. Microbiol. 54(Pt 4), 385-389 (2005). (Pubitemid 40489546)
235. Yilmaz GR, Buzgan T, Irmak H et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007. Int. J. Infect. Dis. 13(3), 380-386 (2009).
236. Ertugrul B, Uyar Y, Yavas K et al. An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey. Int. J. Infect. Dis. 13(6), e431-e436 (2009).
237. Papa A, Maltezou HC, Tsiodras S et al. A case of Crimean-Congo haemorrhagic fever in Greece, June 2008. Euro. Surveill. 13(33), pii: 18952 (2008).
238. Deyde VM, Khristova ML, Rollin PE, Ksiazek TG, Nichol ST. Crimean-Congo hemorrhagic fever virus genomics and global diversity. J. Virol. 80(17), 8834-8842 (2006). (Pubitemid 44384893)
239. Hewson R, Chamberlain J, Mioulet V et al. Crimean-Congo haemorrhagic fever virus: sequence analysis of the small RNA segments from a collection of viruses world wide. Virus Res. 102(2), 185-189 (2004). (Pubitemid 38490334)
240. Anagnostou V, Papa A. Evolution of Crimean-Congo hemorrhagic fever virus. Infect. Genet. Evol. 9(5), 948-954 (2009).
241. Midilli K, Gargili A, Ergonul O et al. The first clinical case due to AP92 like strain of Crimean-Congo hemorrhagic fever virus and a feld survey. BMC Infect. Dis. 9, 90 (2009).
242. Estrada-Pena A. Tick-borne pathogens, transmission rates and climate change. Front Biosci. 14, 2674-2687 (2009).
243. Mediannikov O, Matsumoto K, Samoylenko I et al. Rickettsia raoultii sp. nov., a spotted fever group Rickettsia associated with Dermacentor ticks in Europe and Russia. Int. J. Syst. Evol. Microbiol. 58(Pt 7), 1635-1639 (2008).
244. Parola P, Rovery C, Rolain JM, Brouqui P, Davoust B, Raoult D. Rickettsia slovaca and R. raoultii in tick-borne Rickettsioses. Emerg. Infect. Dis. 15(7), 1105-1108 (2009).